GrowGeneration Corp Aktie News

Although reform has been the biggest market mover for marijuana stocks, earnings could have a similar impact. Companies are planning on reporting their Q3 2025 earnings. If these financial reports continue to exceed expectations for some companies, this could set off some upward trading. At times when several marijuana stocks begin to trade well, this speculation leads to more trading in the se...

DENVER, Oct. 23, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation's largest specialty hydroponic and organic gardening retailer, today announced it will release its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after market close. The announcement will be followed by a live earnings conferenc...

The U.S. cannabis industry continues to grow rapidly as legalization momentum spreads across new states. According to recent data, the market is projected to exceed $35 billion in annual sales by 2025. Additionally, analysts expect the industry to reach over $70 billion by 2030 as federal reform progresses. Last week, renewed discussions in Congress surrounding cannabis rescheduling lifted inve...

Most marijuana stock investors are keeping a core focus on the future. At one point in time, most cannabis stocks had fast turnarounds for making a profit. However, this has not been the case for a long while. In fact, since the pandemic, there has been an overwhelming drop in trading in that sector. Now, with a bigger push for federal reform and other rules and regulatory issues being worked o...

The U.S. cannabis industry is gaining momentum again, and ancillary stocks are attracting investor attention this week. The legal market generated over $30 billion in sales last year and could exceed $50 billion by 2030. Ancillary companies provide vital tools, marketplaces, and supplies, making them less exposed to direct regulation. Recent headlines highlight renewed discussions in Congress a...

The U.S. cannabis industry continues to expand, with annual sales expected to surpass 40 billion dollars in 2025. Market forecasts suggest long-term growth as more states approve medical and recreational use. Recent discussions on federal legalization have also reignited investor interest. These developments provide a favorable backdrop for ancillary companies, which support the industry withou...

For cannabis investors, watching the industry's growth brings hope. Especially with how volatile the sector can get, even when public companies do well as a business, it does not resonate in the stock market. In recent news, Q2 earnings have been released for most publicly traded cannabis companies. Some companies have reported that they are still generating decent revenue. For others, beyond s...

I recommend a modest BUY position in GrowGeneration, leveraging a covered call strategy for enhanced returns with limited risk. The near-term call option sale offers a 5.8% return in 39 days, annualizing to 54.7%, with strong liquidity in GRWG options. Upside for GrowGeneration hinges on cannabis rescheduling and removal of 280E taxation, which would benefit its core customers.